Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		35,552,795
Beginning balance at Dec. 31, 2020	$ 283,061	$ 3	$ 400,918	$ (32)	$ (117,828)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock awards (in shares)		103,164
Vesting of restricted stock awards	9		9
Option exercises (in shares)		427,342
Option exercises	2,984		2,984
Stock-based compensation expense	10,437		10,437
Net unrealized loss on short-term investments	(169)			(169)
Net loss	$ (97,263)				(97,263)
Ending balance (in shares) at Dec. 31, 2021	36,083,301	36,083,301
Ending balance at Dec. 31, 2021	$ 199,059	$ 3	414,348	(201)	(215,091)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock awards (in shares)		21,841
Vesting of restricted stock awards	2		2
Option exercises (in shares)		403,680
Option exercises	1,360		1,360
Stock-based compensation expense	22,598		22,598
Net unrealized loss on short-term investments	(1,757)			(1,757)
Issuance of common stock upon initial public offering/private placement (in shares)		12,432,432
Issuance of common stock upon initial public offering/private placement	215,401	$ 2	215,399
Net loss	$ (123,321)				(123,321)
Ending balance (in shares) at Dec. 31, 2022	48,941,254	48,941,254
Ending balance at Dec. 31, 2022	$ 313,342	$ 5	$ 653,707	$ (1,958)	$ (338,412)